VeriMomgarcinia mangostana peel extract est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive hazard; peer‑reviewed literature contains pharmacology/toxicity studies but no consistent in vivo reproductive/teratology data indicating teratogenicity. Topical cosmetic exposure is expected to give low but measurable systemic exposure for typical extract constituents (PubChem/CosIng data), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no clear reproductive/teratology evidence), PubChem/CosIng.
Pregnancy-safe products containing garcinia mangostana peel extract
Related ingredients
Frequently asked questions
- garcinia mangostana peel extract est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive hazard; peer‑reviewed literature contains pharmacology/toxicity studies but no consistent in vivo reproductive/teratology data indicating teratogenicity. Topical cosmetic exposure is expected to give low but measurable systemic exposure for typical extract constituents (PubChem/CosIng data), so exposure scored as low (1). Sources consulted: ECHA Annex VI (no harmonised classification), PubMed (no clear reproductive/teratology evidence), PubChem/CosIng.
- garcinia mangostana peel extract est-il sûr pendant l'allaitement ?
- No authoritative evidence of reproductive or lactation-specific toxicity or harmonised hazard classifications. Lipophilic small molecules in extracts could theoretically transfer into milk if systemically absorbed, but no data demonstrating this for mangosteen peel extract or major xanthones; therefore hazard and mechanism remain 0 and exposure scored as low (1). Sources: ECHA Annex VI, PubMed, PubChem/CosIng.
- garcinia mangostana peel extract est-il sûr pour la peau de bébé ?
- No infant-specific reproductive or developmental toxicity data found; no regulatory flags. Because infant skin has higher absorption (immature barrier, higher surface‑area‑to‑weight), exposure rating increased by +1 relative to adults (adult exposure scored 1 → infant 2). No evidence to change hazard or mechanism. Sources: PubMed (no infant toxicity data), CosIng/PubChem (ingredient identity/properties), ECHA Annex VI (no harmonised classification).
- Comment VeriMom évalue-t-il garcinia mangostana peel extract ?
- VeriMom évalue garcinia mangostana peel extract à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à garcinia mangostana peel extract pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à garcinia mangostana peel extract basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.